Business Context and Reporting Period
This Form 8-K Current Report, dated November 1, 2023, details material agreements entered into by Forum Energy Technologies, Inc. (Forum). The primary event is the execution of a Stock Purchase Agreement to acquire Variperm Holdings Ltd. and related entities, alongside an amendment to Forum's existing credit facility to facilitate the transaction.
Key Financial Metrics and Transaction Terms
- Acquisition Consideration: The total closing consideration consists of 2.0 million shares of Forum Common Stock and $150.0 million in cash, subject to customary purchase price adjustments.
- Financing Structure: Sellers have agreed to provide up to $60.0 million in seller financing via a term loan maturing in December 2026. The initial interest rate is 11% with escalation provisions after the first anniversary.
- Debt Facility Amendment: Forum amended its Credit Agreement to increase aggregate revolving commitments from $179.0 million to $250.0 million. Upon closing, the maturity date will extend to September 8, 2028.
- Refinancing Capacity: The amended agreement permits the incurrence of new secured notes up to $200.0 million to refinance existing secured notes.
Material Changes and Agreements
The filing reports the entry into a definitive agreement to acquire Variperm, which will become a wholly-owned subsidiary of Forum Canada ULC. Concurrently, Forum amended its Third Amended and Restated Credit Agreement to accommodate the transaction, update interest rate benchmarks (CDOR to Term CORRA), and increase liquidity capacity. Additionally, Dr. Emily Reichert retired from the Board of Directors effective November 2, 2023, to accept a CEO role at the Massachusetts Clean Energy Center.
Outlook, Risks, and Conditions
- Closing Conditions: The transaction is subject to regulatory approval under the Competition Act (Canada), NYSE listing approval for the new shares, and the absence of a Material Adverse Effect.
- Termination Rights: The agreement may be terminated if the transaction is not consummated by April 30, 2024, or in the event of specific breaches.
- Shareholder Restrictions: An investor rights agreement includes a 180-day lock-up on the shares issued to sellers and a standstill agreement for stockholders owning 5.0% or more of Forum Common Stock for two years post-closing.
- Financial Impact: The filing does not provide specific revenue, profit, or cash flow projections for the combined entity, nor does it detail the immediate impact on Forum's standalone financial metrics.
Investor Verification Checklist
- Verify the final purchase price adjustments regarding Variperm's cash, net working capital, and indebtedness at closing.
- Confirm the status of regulatory approvals required under the Competition Act (Canada).
- Review the full text of the Credit Agreement Amendment (Exhibit 10.1) for specific covenants and financial maintenance requirements.
- Monitor the utilization of the $60.0 million Seller Term Loan and its impact on future interest expense.
- Check for any updates regarding the NYSE listing approval for the 2.0 million shares to be issued.